Search Results - "RAFALSKIY, VLADIMIR V."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    1704-P: Efficacy and Safety of Tirzepatide for Weight Loss—A Meta-analysis of Randomized Controlled Trials by MESQUITA, YASMIN L.L., CALVI, IZABELA P., MARQUES, ISABELA R., CRUZ, SARA A., PADRAO, EDUARDO M.H., CARDOSO, RHANDERSON, MOURA, FILIPE, RAFALSKIY, VLADIMIR V.

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Tirzepatide (TZP) is a new dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist approved for type 2 diabetes and…”
    Get full text
    Journal Article
  3. 3

    Modern doctors' view on the problem of diagnostics and treatment of asthenic syndrome in different regions of the Russian Federation by Belousova, Yana D., Tynterova, Anastasiya M., Rafalskiy, Vladimir V.

    “…Introduction: The problem of asthenic disorders is determined by their high prevalence, the lack of diagnostic criteria and recommendations for therapy, and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2) by Dedov, Ivan I., Kalashnikova, Marina F., Belousov, Dmitriy Y., Rafalskiy, Vladimir V., Kalashnikov, Victor Y., Kolbin, Aleksey S., Yazykova, Diana R., Ivanenko, Leonid R.

    Published in Sakharnyĭ diabet (02-12-2016)
    “…Rationale. The rising incidence of type 2 diabetes mellitus (T2DM) allows researchers to conduct observational multicentre studies and obtain objective…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11